Psychiatry
Major Depression
0
Pipeline Programs↗
14
Active Trials↗
12
Companies Involved↗
Major Depression is an early-stage landscape with 0 programs across 12 companies. The most active players are Corcept Therapeutics, Eli Lilly, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
122
clinical trials
Completed83 · 68%
Unknown status13 · 11%
Recruiting11 · 9%
Terminated9 · 7%
Withdrawn3 · 2%
Not yet recruiting3 · 2%
Clinical Trials
Trial Activity
122 trials
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Recruiting·SSection for Affective Disorders; Northern Stockholm Psychiatry·Phase 2·NCT06319378·100 enrolled
A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression
Recruiting·—·Phase 2·NCT07396272·12 enrolled
Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
Recruiting·—·N/A·NCT05909267·165 enrolled
Effect of Psychobioticsbe (Combined Lactobacillus Helveticus and Bifidobacterium Longus) With Standard Antiddepressants in Treatment of Major Depressive Disorder
Recruiting·—·Preclinical·NCT07691749·86 enrolled
Page 1 of 9
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)